[English] 日本語
Yorodumi
- PDB-5f20: Structure of TYK2 with inhibitor 4: 3-azanyl-5-(2-methylphenyl)-7... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 5f20
TitleStructure of TYK2 with inhibitor 4: 3-azanyl-5-(2-methylphenyl)-7-(1-methylpyrazol-3-yl)-1~{H}-pyrazolo[4,3-c]pyridin-4-one
ComponentsNon-receptor tyrosine-protein kinase TYK2
KeywordsTRANSFERASE/TRANSFERASE INHIBITOR / kinase / TRANSFERASE-TRANSFERASE INHIBITOR complex
Function / homology
Function and homology information


type III interferon-mediated signaling pathway / interleukin-10-mediated signaling pathway / interleukin-12 receptor complex / interleukin-23 receptor complex / Interleukin-23 signaling / positive regulation of T-helper 17 type immune response / interleukin-12-mediated signaling pathway / type 1 angiotensin receptor binding / positive regulation of NK T cell proliferation / Interleukin-12 signaling ...type III interferon-mediated signaling pathway / interleukin-10-mediated signaling pathway / interleukin-12 receptor complex / interleukin-23 receptor complex / Interleukin-23 signaling / positive regulation of T-helper 17 type immune response / interleukin-12-mediated signaling pathway / type 1 angiotensin receptor binding / positive regulation of NK T cell proliferation / Interleukin-12 signaling / Interleukin-27 signaling / IL-6-type cytokine receptor ligand interactions / Interleukin-35 Signalling / positive regulation of natural killer cell proliferation / growth hormone receptor binding / extrinsic component of plasma membrane / Other interleukin signaling / Interleukin-20 family signaling / type I interferon-mediated signaling pathway / Interleukin-6 signaling / MAPK3 (ERK1) activation / extrinsic component of cytoplasmic side of plasma membrane / positive regulation of interleukin-17 production / Interleukin-10 signaling / MAPK1 (ERK2) activation / cell surface receptor signaling pathway via JAK-STAT / Regulation of IFNA/IFNB signaling / type II interferon-mediated signaling pathway / growth hormone receptor signaling pathway via JAK-STAT / Signaling by CSF3 (G-CSF) / positive regulation of T cell proliferation / non-specific protein-tyrosine kinase / non-membrane spanning protein tyrosine kinase activity / positive regulation of receptor signaling pathway via JAK-STAT / Inactivation of CSF3 (G-CSF) signaling / cellular response to virus / Evasion by RSV of host interferon responses / cytokine-mediated signaling pathway / positive regulation of protein localization to nucleus / cytoplasmic side of plasma membrane / positive regulation of type II interferon production / Interferon alpha/beta signaling / Signaling by ALK fusions and activated point mutants / protein tyrosine kinase activity / Interleukin-4 and Interleukin-13 signaling / Potential therapeutics for SARS / cell differentiation / cytoskeleton / intracellular signal transduction / immune response / protein phosphorylation / SARS-CoV-2 activates/modulates innate and adaptive immune responses / extracellular exosome / ATP binding / nucleus / plasma membrane / cytosol / cytoplasm
Similarity search - Function
Tyrosine-protein kinase, non-receptor, TYK2, N-terminal / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / : / Jak1 pleckstrin homology-like domain / FERM F2 acyl-CoA binding protein-like domain / FERM F1 ubiquitin-like domain / FERM superfamily, second domain ...Tyrosine-protein kinase, non-receptor, TYK2, N-terminal / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / : / Jak1 pleckstrin homology-like domain / FERM F2 acyl-CoA binding protein-like domain / FERM F1 ubiquitin-like domain / FERM superfamily, second domain / FERM domain / FERM domain profile. / Band 4.1 domain / Band 4.1 homologues / Src homology 2 domains / SH2 domain / SH2 domain superfamily / Tyrosine-protein kinase, catalytic domain / Tyrosine kinase, catalytic domain / Tyrosine protein kinases specific active-site signature. / Tyrosine-protein kinase, active site / Serine-threonine/tyrosine-protein kinase, catalytic domain / Protein tyrosine and serine/threonine kinase / Transferase(Phosphotransferase) domain 1 / Transferase(Phosphotransferase); domain 1 / Phosphorylase Kinase; domain 1 / Phosphorylase Kinase; domain 1 / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / 2-Layer Sandwich / Orthogonal Bundle / Mainly Alpha / Alpha Beta
Similarity search - Domain/homology
Chem-5U4 / Non-receptor tyrosine-protein kinase TYK2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2.91 Å
AuthorsSkene, R.J.
CitationJournal: J.Med.Chem. / Year: 2016
Title: Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors.
Authors: Yogo, T. / Nagamiya, H. / Seto, M. / Sasaki, S. / Shih-Chung, H. / Ohba, Y. / Tokunaga, N. / Lee, G.N. / Rhim, C.Y. / Yoon, C.H. / Cho, S.Y. / Skene, R. / Yamamoto, S. / Satou, Y. / Kuno, M. ...Authors: Yogo, T. / Nagamiya, H. / Seto, M. / Sasaki, S. / Shih-Chung, H. / Ohba, Y. / Tokunaga, N. / Lee, G.N. / Rhim, C.Y. / Yoon, C.H. / Cho, S.Y. / Skene, R. / Yamamoto, S. / Satou, Y. / Kuno, M. / Miyazaki, T. / Nakagawa, H. / Okabe, A. / Marui, S. / Aso, K. / Yoshida, M.
History
DepositionDec 1, 2015Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jan 13, 2016Provider: repository / Type: Initial release
Revision 1.1Jan 20, 2016Group: Database references
Revision 1.2Feb 10, 2016Group: Database references
Revision 1.3Mar 6, 2024Group: Data collection / Database references / Derived calculations
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / citation / database_2 / pdbx_struct_oper_list
Item: _citation.journal_id_CSD / _database_2.pdbx_DOI ..._citation.journal_id_CSD / _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_struct_oper_list.symmetry_operation

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Non-receptor tyrosine-protein kinase TYK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)35,1652
Polymers34,8451
Non-polymers3201
Water55831
1


  • Idetical with deposited unit
  • defined by author&software
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area0 Å2
ΔGint0 kcal/mol
Surface area13500 Å2
MethodPISA
Unit cell
Length a, b, c (Å)48.332, 48.332, 477.344
Angle α, β, γ (deg.)90.000, 90.000, 120.000
Int Tables number178
Space group name H-MP6122

-
Components

#1: Protein Non-receptor tyrosine-protein kinase TYK2


Mass: 34844.863 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: TYK2 / Production host: unidentified baculovirus
References: UniProt: P29597, non-specific protein-tyrosine kinase
#2: Chemical ChemComp-5U4 / 3-azanyl-5-(2-methylphenyl)-7-(1-methylpyrazol-3-yl)-1~{H}-pyrazolo[4,3-c]pyridin-4-one


Mass: 320.349 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C17H16N6O
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 31 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.31 Å3/Da / Density % sol: 46.74 %
Crystal growTemperature: 293 K / Method: vapor diffusion, sitting drop / pH: 6
Details: 15% PEG 5000 MME, and 100 mM Sodium Citrate (pH 6.0)

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: ALS / Beamline: 5.0.3 / Wavelength: 0.98 Å
DetectorType: ADSC QUANTUM 4 / Detector: CCD / Date: Dec 7, 2011
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.98 Å / Relative weight: 1
ReflectionRedundancy: 8.8 % / Number: 71029 / Rmerge(I) obs: 0.13 / Χ2: 1 / D res high: 2.9 Å / D res low: 50 Å / Num. obs: 8088 / % possible obs: 95.8
Diffraction reflection shell
Highest resolution (Å)Lowest resolution (Å)IDRmerge(I) obsChi squaredRedundancy
7.865010.0380.986.9
6.247.8610.0750.9978.2
5.466.2410.1161.0468.5
4.965.4610.1191.0368.9
4.64.9610.1011.0038.9
4.334.610.0950.9849.2
4.114.3310.1040.9749.4
3.944.1110.1371.0369.2
3.783.9410.1390.9899.5
3.653.7810.2221.069.4
3.543.6510.2020.9779.7
3.443.5410.2110.9989.6
3.353.4410.3011.0179.2
3.273.3510.4181.0099.2
3.193.2710.6781.0088.9
3.123.1910.6120.9948
3.063.1210.5530.958.5
33.0610.6891.0558.3
2.95310.8470.9957.8
2.92.9510.7820.9578.9
ReflectionResolution: 2.9→50 Å / Num. obs: 8088 / % possible obs: 95.8 % / Redundancy: 8.8 % / Rmerge(I) obs: 0.13 / Χ2: 1.004 / Net I/av σ(I): 13.667 / Net I/σ(I): 5.7 / Num. measured all: 71029
Reflection shell

Diffraction-ID: 1 / Rejects: _

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. unique allΧ2% possible all
2.9-2.958.90.7822490.95763.2
2.95-37.80.8473090.99573.4
3-3.068.30.6893251.05585.5
3.06-3.128.50.5533600.9592.3
3.12-3.1980.6124070.99498.3
3.19-3.278.90.6783891.00899.7
3.27-3.359.20.4184051.009100
3.35-3.449.20.3014191.017100
3.44-3.549.60.2113940.998100
3.54-3.659.70.2024010.977100
3.65-3.789.40.2224091.06100
3.78-3.949.50.1394040.989100
3.94-4.119.20.1374311.036100
4.11-4.339.40.1044150.974100
4.33-4.69.20.0954180.984100
4.6-4.968.90.1014331.003100
4.96-5.468.90.1194321.036100
5.46-6.248.50.1164521.046100
6.24-7.868.20.0754700.997100
7.86-506.90.0385660.9899.8

-
Phasing

PhasingMethod: molecular replacement
Phasing MRRfactor: 46.24 / Model details: Phaser MODE: MR_AUTO
Highest resolutionLowest resolution
Rotation2.91 Å41.7 Å
Translation2.91 Å41.7 Å

-
Processing

Software
NameVersionClassification
REFMACrefinement
HKL-2000data collection
SCALEPACKdata scaling
PHASER2.1.4phasing
PDB_EXTRACT3.15data extraction
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 2.91→30 Å / Cor.coef. Fo:Fc: 0.958 / Cor.coef. Fo:Fc free: 0.907 / WRfactor Rfree: 0.2735 / WRfactor Rwork: 0.1757 / FOM work R set: 0.7392 / SU B: 54.37 / SU ML: 0.463 / SU R Cruickshank DPI: 0.3461 / SU Rfree: 0.4787 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R Free: 0.479 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: U VALUES : WITH TLS ADDED
RfactorNum. reflection% reflectionSelection details
Rfree0.2877 359 4.6 %RANDOM
Rwork0.2013 ---
obs0.2055 7505 94.62 %-
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK
Displacement parametersBiso max: 188.74 Å2 / Biso mean: 96.157 Å2 / Biso min: 37.14 Å2
Baniso -1Baniso -2Baniso -3
1-4.76 Å22.38 Å20 Å2
2--4.76 Å20 Å2
3----7.13 Å2
Refinement stepCycle: final / Resolution: 2.91→30 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2244 0 24 31 2299
Biso mean--88.4 64.26 -
Num. residues----274
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0090.0192329
X-RAY DIFFRACTIONr_angle_refined_deg1.3071.9813152
X-RAY DIFFRACTIONr_dihedral_angle_1_deg6.2775270
X-RAY DIFFRACTIONr_dihedral_angle_2_deg40.54123.333111
X-RAY DIFFRACTIONr_dihedral_angle_3_deg20.0215402
X-RAY DIFFRACTIONr_dihedral_angle_4_deg17.7451515
X-RAY DIFFRACTIONr_chiral_restr0.0870.2331
X-RAY DIFFRACTIONr_gen_planes_refined0.0050.0211785
LS refinement shellResolution: 2.906→2.981 Å / Total num. of bins used: 20
RfactorNum. reflection% reflection
Rfree0.399 17 -
Rwork0.417 360 -
all-377 -
obs--64.33 %
Refinement TLS params.Method: refined / Origin x: 23.686 Å / Origin y: -15.773 Å / Origin z: 15.887 Å
111213212223313233
T0.4573 Å2-0.006 Å20.0194 Å2-0.1366 Å20.0131 Å2--0.2797 Å2
L2.2453 °2-0.5302 °2-0.4157 °2-1.4434 °2-1.8756 °2--10.9701 °2
S0.1488 Å °-0.3238 Å °0.1049 Å °-0.5187 Å °-0.1156 Å °-0.057 Å °1.0462 Å °-0.1714 Å °-0.0331 Å °

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more